Experimental study demonstrates a 3-day rapid sterility test using automated enrichment and qPCR in cell therapies, indicating potential for faster batch release of biopharmaceuticals.
In this article, we present a rapid sterility method with a time to detection of 3 days and a limit of detection (LOD) of 1 CFU for testing both cell-therapy drug products and E. coli DNA plasmid preparations. The new method combines the automated rapid sterility test system BacT/ALERT (bioMérieux) as an enrichment step with PCR detection of viable microorganisms via the ATMP sterile release qPCR assay (Sartorius). Sample preparation protocols for non-filterable cell-therapy drug products and cell-free E. coli DNA plasmid preparations were developed; these include removal of contaminating DNA and PCR inhibitors and the use of a physical lysis step. A validation of the rapid sterility method using the BacT/ALERT system is presented and pre-validation experiments for the full assay are described.
No takes yet. Share an insight, caveat, or question.
Wallace et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: